• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Stem Cell Therapy Companies

    ID: MRFR/Pharma/4961-CR
    200 Pages
    Rahul Gotadki
    July 2025

    Stem cell therapy involves the use of stem cells to treat or prevent diseases or conditions. These cells have the unique ability to differentiate into various cell types, making them valuable for regenerative medicine.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Stem Cell Therapy Market Research Report—Global Forecast till 2035 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the Stem Cell Therapy Market

    Stem Cell Therapy CompaniesLatest Stem Cell Therapy Companies Update



    • July 2023: In July of 2023, biopharmaceutical startup Abeona Therapeutics announced that it has raised $25 million from a select group of current investors to forward development of its primary medicine, EB-101. The company intends to use the funds to be ready for the introduction of EB-101 and the filing of the BLA. EB-101 is an autologous, engineered cell therapy for the skin disorder recessive dystrophic epidermolysis bullosa. The company can submit a request for a priority review voucher (PRV) from the FDA after the BLA has been granted since the medicine treats a rare pediatric ailment.




    • August 2023: The FDA approved ANPD001, an investigational stem cell treatment developed by Aspen Neuroscience to restore damaged nerve cells in Parkinson's disease patients. The open-label Phase 1/2a trial is designed to examine the early effectiveness, safety, and dose-ranging tolerability of ANPD001 in patients with moderate to severe Parkinson's disease. More than a million individuals in the United States and 10 million people globally suffer from Parkinson's disease; FDA approval opens the door to a new treatment. Dopaminergic neurons are destroyed in Parkinson's disease, and ANPD001 is designed to restore them. There are three stages involved in the production of the stem cell treatment.




    • October 2023: In order to meet the growing demand for cell treatments throughout the world, Bayer AG announced in October 2023 that it would be constructing a Cell Therapy Launch Facility in Berkeley, California. BlueRock Therapeutics' bemdaneprocel (BRT-DA01) is an experimental cell therapy being studied for the treatment of Parkinson's disease. The $250 million (USD), 100,000 square foot facility will supply the material necessary for late-stage clinical studies and perhaps a commercial launch. It also has room for an extra production suite module to accommodate Bayer's expanding cell therapy range. Clinical-stage cell treatment firm BlueRock Therapeutics LP is a wholly-owned, separately managed subsidiary of Bayer AG.


    List of Stem Cell Therapy Key companies in the market

    • Seraxis, Inc. (Germany)

    • ViaCyte, Inc. (US)

    • Betalin Therapeutics Ltd (Israel)

    • NextCell Pharma AB (US)

    • Kadimastem (Israel)

    • Vertex Pharmaceuticals (US)

    • Fresenius Medical Care AG & Co. KGaA (Germany)

    • Sernava Corp (Canada)

    • Novo Nordisk A/S (Denmark)

    • Generex Biotechnology (Canada)